TABLE 3.
Comparison between patients with diaphragm dysfunction or paralysis versus patients with normal diaphragm function after COVID-19 severe pneumonia.
| Parameters | Patients | P-value | |
|
|
|||
| Hemidiaphragm dysfunction or paralysis | Normal diaphragm function | ||
| Number of patients | 13 | 119 | |
| Age (years) | 57 ± 17 | 56 ± 10 | NS |
| Weight (kg) | 72 ± 19 | 81 ± 16 | NS |
| Height (cm) | 169 ± 8 | 169 ± 9 | NS |
| BMI (kg–1 m2) | 26 ± 6 | 28 ± 5 | NS |
| Comorbidity (in percentage) | |||
| Hypertension | 46 | 32 | NS |
| Cardiovascular disease | 15 | 17 | NS |
| Obesity | 31 | 34 | NS |
| Diabetes | 15 | 28 | NS |
| COPD | 15 | 8 | NS |
| Sleep apnea | 8 | 14 | NS |
| Cardiothoracic procedure or upper abdominal surgery | 46 | 10 | <0.001 |
| Clinical impairments (in percentage) | |||
| Dyspnea | 85 | 64 | NS |
| Chest pain | 15 | 24 | NS |
| Cough | 31 | 24 | NS |
| Amnestic disorders | 31 | 16 | NS |
| Myalgia | 54 | 23 | <0.05 |
| Dysesthesia | 31 | 32 | NS |